Exploring the Potential of Terpenoids as a Possible Treatment for Cancer: Structure-activity Relationship and

Arshdeep Singh1, Rabin Debnath1, Anjali Sharma1

  • 1Department of Pharmaceutical Chemistry, Indo Soviet Friendship College of Pharmacy, G.T Road, Ghal Kalan, Moga, Punjab, 142001, India.

Current Medicinal Chemistry
|September 25, 2024
PubMed

Insights

Terpenoids, natural compounds from plants, show significant anticancer potential against various cancers. Understanding their structure-activity relationship is key to developing new, effective cancer therapies.

Area of Science:

  • Natural Product Chemistry
  • Pharmacology
  • Oncology

Background:

  • Cancer presents a major global health challenge, necessitating novel therapeutic strategies to overcome limitations like metastasis and chemoresistance.
  • Plant-derived terpenoids are a promising class of natural compounds with demonstrated anticancer properties.
  • Identifying key structural features of terpenoids is crucial for designing effective anticancer agents.

Purpose of the Study:

  • To investigate the anticancer activity of specific terpenoids against prevalent human malignancies.
  • To explore the structure-activity relationships (SAR) of these terpenoids.
  • To elucidate the mechanisms underlying their anticancer effects.

Main Methods:

  • Literature review of existing research on terpenoids and their anticancer activities.
  • Analysis of structural features of various terpenoid derivatives.
  • Correlation of structural characteristics with observed anticancer efficacy against different cancer cell types.

Main Results:

  • Terpenoids exhibit anticancer effects by targeting critical cancer development stages, including cell cycle arrest, differentiation inhibition, and apoptosis induction.
  • Specific terpenoids show significant activity against breast, colon, ovarian, and lung cancer cell lines.
  • Structure-activity relationship analysis identified essential structural motifs for potent anticancer activity.

Conclusions:

  • Terpenoids represent a valuable resource for developing novel anticancer drugs.
  • Further research into terpenoid SAR can guide the design of more effective and targeted cancer therapies.
  • These natural compounds offer a promising avenue for combating diverse cancer types with reduced toxicity.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
204